Altogether, the pathogenic forms of tau-mediated mitochondrial alterations—including impaired balance of mitochondrial fusion and fission, reduced mitochondrial motility, and excessive mitophagy—ultimately interfere with mitochondrial quality control, thus contributing to mitochondrial dysfunction in AD. This evidence concerns the gene MAPT and Alzheimer disease.